Scandinavian ChemoTech AB Class B(SE:NEEMS.B)
kr 2.000.00 (0.00%)
SE:NEEMS.B
Scandinavian ChemoTech AB Class B financials statements
kr 2.00
At close:0.00 (0.00%)
Want to see SE:NEEMS.B full AI Analyst Report?
Scandinavian ChemoTech AB Class B (NEEMS.B) Ratios
1 Followers
Scandinavian ChemoTech AB Class B Ratios
SE:NEEMS.B's free cash flow for Q1 2026 was kr-1.14M. For the 2026 fiscal year, SE:NEEMS.B's free cash flow was increased by kr0.00 and operating cash flow was kr-1.14M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.91 | 1.05 | 1.88 | 1.53 | 7.10 |
| Quick Ratio | 0.63 | 0.60 | 0.82 | 1.13 | 5.91 |
| Cash Ratio | 0.37 | 0.13 | 0.24 | 0.76 | 4.59 |
| Solvency Ratio | -0.61 | -1.83 | -5.47 | -2.95 | -9.35 |
| Operating Cash Flow Ratio | -0.37 | -1.78 | -4.75 | -2.55 | -10.13 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | -361.94 |
| Net Current Asset Value | kr -876.00K | kr 370.00K | kr 3.36M | kr 4.11M | kr 11.54M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 4.14 | 2.24 | 1.35 | 1.55 | 1.08 |
| Debt Service Coverage Ratio | -2.22 | -10.51 | -13.96 | -11.94 | -24.31 |
| Interest Coverage Ratio | -3.24 | -10.86 | -14.42 | -11.02 | -25.30 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.08 | 0.05 | 0.10 | 0.19 | 0.08 |
| Net Debt to EBITDA | 0.85 | 0.08 | 0.05 | 0.28 | 0.51 |
| Profitability Margins | |||||
| Gross Profit Margin | -36.61% | 72.75% | 58.72% | -11.63% | 659.18% |
| EBIT Margin | -51.30% | -190.97% | -697.66% | -4407.82% | -34832.65% |
| EBITDA Margin | -35.24% | -188.49% | -693.80% | -4399.15% | -34746.94% |
| Operating Profit Margin | -51.30% | -194.88% | -717.12% | -4421.14% | -34851.02% |
| Pretax Profit Margin | -65.58% | -208.91% | -747.38% | -4808.88% | -36210.20% |
| Net Profit Margin | -65.58% | -208.91% | -747.38% | -4808.88% | -36210.20% |
| Continuous Operations Profit Margin | -65.58% | -208.91% | -747.38% | -4808.88% | -36210.20% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 127.83% | 107.20% | 104.22% | 108.77% | 103.90% |
| Return on Assets (ROA) | -61.03% | -102.52% | -141.85% | -104.82% | -68.74% |
| Return on Equity (ROE) | -252.86% | -229.38% | -191.20% | -162.56% | -74.19% |
| Return on Capital Employed (ROCE) | -197.80% | -213.98% | -183.46% | -149.46% | -71.40% |
| Return on Invested Capital (ROIC) | -197.80% | -213.98% | -183.46% | -149.46% | -72.83% |
| Return on Tangible Assets | -85.59% | -172.76% | -284.25% | -185.30% | -129.90% |
| Earnings Yield | -6.68% | -32.83% | -63.93% | -47.05% | -12.52% |
| Efficiency Ratios | |||||
| Receivables Turnover | 4.59 | 1.87 | 1.26 | 0.16 | 0.08 |
| Payables Turnover | 9.05 | 1.26 | 0.49 | 0.29 | -0.27 |
| Inventory Turnover | 6.01 | 0.54 | 0.29 | 0.17 | -0.12 |
| Fixed Asset Turnover | 103.24 | 1641.50 | 235.17 | 13.51 | 0.67 |
| Asset Turnover | 0.93 | 0.49 | 0.19 | 0.02 | 0.00 |
| Working Capital Turnover Ratio | -48.56 | 3.52 | 0.76 | 0.06 | 0.01 |
| Cash Conversion Cycle | 99.93 | 580.63 | 804.37 | 3096.78 | 3179.90 |
| Days of Sales Outstanding | 79.51 | 195.23 | 290.24 | 2214.69 | 4834.39 |
| Days of Inventory Outstanding | 60.76 | 675.12 | 1263.87 | 2140.23 | -2998.59 |
| Days of Payables Outstanding | 40.34 | 289.71 | 749.74 | 1258.14 | -1344.11 |
| Operating Cycle | 140.27 | 870.35 | 1554.11 | 4354.92 | 1835.79 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.16 | -0.56 | -1.30 | -1.97 | -2.22 |
| Free Cash Flow Per Share | -0.17 | -0.57 | -1.35 | -2.00 | -2.58 |
| Dividend Paid and CapEx Coverage Ratio | -8.57 | -285.76 | -26.80 | -59.31 | -6.03 |
| Capital Expenditure Coverage Ratio | -8.57 | -285.76 | -26.80 | -59.31 | -6.03 |
| Operating Cash Flow Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | -361.94 |
| Operating Cash Flow to Sales Ratio | -0.30 | -2.00 | -6.46 | -41.50 | -391.49 |
| Free Cash Flow Yield | -3.47% | -31.57% | -57.31% | -41.29% | -15.78% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -14.76 | -3.03 | -1.56 | -2.13 | -7.99 |
| Price-to-Sales (P/S) Ratio | 9.82 | 6.36 | 11.69 | 102.22 | 2891.75 |
| Price-to-Book (P/B) Ratio | 37.86 | 6.99 | 2.99 | 3.46 | 5.92 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -28.84 | -3.17 | -1.74 | -2.42 | -6.34 |
| Price-to-Operating Cash Flow Ratio | -32.21 | -3.18 | -1.81 | -2.46 | -7.39 |
| Price-to-Earnings Growth (PEG) Ratio | 0.35 | 0.05 | 0.05 | -0.19 | 0.59 |
| Enterprise Value Multiple | -27.01 | -3.30 | -1.64 | -2.04 | -7.82 |
| Enterprise Value | 116.94M | 40.84M | 32.07M | 42.50M | 133.07M |
| EV to EBITDA | -27.01 | -3.30 | -1.64 | -2.04 | -7.82 |
| EV to Sales | 9.52 | 6.22 | 11.36 | 89.84 | 2715.65 |
| EV to Free Cash Flow | -27.96 | -3.10 | -1.70 | -2.13 | -5.95 |
| EV to Operating Cash Flow | -31.23 | -3.11 | -1.76 | -2.16 | -6.94 |
| Tangible Book Value Per Share | -0.03 | 0.02 | 0.26 | 0.46 | 1.36 |
| Shareholders’ Equity Per Share | 0.13 | 0.26 | 0.79 | 1.40 | 2.76 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | -0.08 | -0.04 |
| Revenue Per Share | 0.51 | 0.28 | 0.20 | 0.05 | 0.01 |
| Net Income Per Share | -0.34 | -0.59 | -1.50 | -2.28 | -2.05 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.28 | 1.09 | 1.07 | 1.09 | 1.04 |
| Research & Development to Revenue | 0.00 | 0.29 | 0.91 | 6.15 | 56.61 |
| SG&A to Revenue | 0.00 | 2.35 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.58 | 1.03 | 0.86 | 0.94 | 1.12 |
Currency in SEK
